Jan 182018
Suven Life Sciences has secured a product patent each from China and Sri Lanka corresponding to the new chemical entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases. The two patents are valid through 2033 and 2032, respectively, the company said in a BSE …